New Agreements Continue 25-Year Relationship and Will Help Speed
New Products to Market
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that
designs, manufactures, and markets innovative microsurgical instruments
and other devices, today announced the signing of a new, three-year
agreement with Codman & Shurtleff, Inc. (“Codman”), an affiliate of
Johnson & Johnson.
Under the terms of the new agreement, Codman will continue to market and
distribute certain bipolar generators and related disposables and
accessories supplied by Synergetics. Additionally, Synergetics and
Codman extended the license agreement providing for the continued
licensing of Synergetics’ Malis® trademark to Codman for use
with certain of its products, including those covered by the
distribution agreement.
“We are pleased to announce our new agreement with Codman,” commented
David Hable, President and Chief Executive Officer of Synergetics USA.
“Codman and Synergetics, through Valley Forge Scientific Corp., have had
a mutually beneficial relationship for over 25 years. With Codman’s
reputation as an industry pioneer and a far reaching market influence,
our continued affiliation with them exposes Synergetics to a large and
capable marketing network and further market penetration. Through the
efforts of both our organizations, we have successfully partnered on
this contract to ensure improved service, efficient production planning,
and close collaboration on product development in order to exceed
customer needs and speed new products to market. Codman is an important
and valued partner of Synergetics and we look forward to our continued
relationship under this agreement,” Hable concluded.
About Synergetics USA, Inc.
Synergetics USA, Inc. is a leading medical device company. Through
continuous improvement and development of our people, our mission is to
design, manufacture and market innovative microsurgical instruments and
consumables of the highest quality in order to assist and enable
surgeons around the world to provide a better quality of life for their
patients. The Company’s primary focus is on the microsurgical
disciplines of ophthalmology and neurosurgery. Our distribution channels
include a combination of direct and independent sales organizations and
important strategic alliances with market leaders. The Company’s product
lines focus upon precision engineered, microsurgical, hand-held
instruments and the microscopic delivery of laser energy, ultrasound,
electrosurgery, illumination and irrigation, often delivered in multiple
combinations.
Forward-Looking Statements
Some statements in this release may be “forward-looking statements”
for the purposes of the Private Securities Litigation Reform Act of
1995. In some cases forward-looking statements can be identified by
words such as “believe,” “expect,” “anticipate,” “plan,” “potential,”
“continue” or similar expressions. Such forward-looking statements
include risks and uncertainties, and there are important facts that
could cause actual results to differ materially from those expressed or
implied by such forward-looking statements. These facts, risks
and uncertainties are discussed in Synergetics’ Annual Report on Form
10-K for the year ended July 31, 2008, as updated from time to time in
our filings with the Securities and Exchange Commission.
Synergetics USA, Inc.
Pamela G. Boone, 636-939-5100
Chief
Financial Officer
http://www.synergeticsusa.com
